Earnings Labs

Mativ Holdings, Inc. (MATV)

Q2 2012 Earnings Call· Thu, Aug 2, 2012

$9.44

-3.08%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

+4.28%

1 Week

+4.50%

1 Month

+3.38%

vs S&P

+0.17%

Transcript

Operator

Operator

Welcome to SWM's Second Quarter 2012 Earnings Conference Call. Hosting the call today from SWM is Frédéric Villoutreix, Chief Executive Officer. He is joined by Jeff Cook, Executive Vice President, Chief Financial Officer and Treasurer; and Scott Humphrey, Corporate Treasury Director. Today's call is being recorded and will be available for replay beginning at noon, Eastern Daylight Time. The dial-in number is (800) 585-8367 and enter PIN number 99972652. [Operator Instructions] It is now my pleasure to turn the floor over to Mr. Humphrey. Sir, you may begin.

Scott Humphrey

Analyst

Thank you, Lori. Good morning. I am Scott Humphrey, Corporate Treasury Director at SWM. Thank you for joining us to discuss SWM's second quarter 2012 earnings results. On today's call, Frédéric will share some high-level comments about our second quarter performance and priority. Jeff will then take you through a more detailed review of our financial results and guidance. We will then take your questions. Before we begin, I would like to remind you that the comments included in today's conference call constitute forward-looking statements. Actual results may differ materially from the results suggested by these comments for a number of reasons, which are discussed in more detail in the company's Securities and Exchange Commission filings, including our annual report on Form 10-K. Certain financial measures discussed during this call exclude restructuring expenses and valuation allowances and are therefore non-GAAP financial measures. I will now turn the call over to Frédéric. Frédéric Villoutreix: Thank you, Scott, and good morning, everyone. Late yesterday, we released our second quarter earnings and I will talk about that in the next several slides. But we also announced a 2-for-1 stock split, the first time in SWM history. This split shows our confidence in the company's long-term strength and it also demonstrates our commitment to increasing shareholder value. Specifically, the stock split has several benefits. For instance, we expect an improvement in market liquidity and our shares should become more accessible, both of which should position SWM as a more attractive investment to a larger shareholder base. Current shareholders will benefit directly, thanks to the doubling of our dividend yield, which is made possible by maintaining the $0.15 per share quarterly dividend in combination with the split. Now, I will comment on our second quarter results as summarized on Slide 4. Improvements in second quarter…

Jeffrey Cook

Analyst · SunTrust

Thank you, Frédéric. Moving to Slide 8. Net sales adjusted for constant currency increased at strong 8.1% for the quarter on higher LIP volume. $13.4 million of the increase in sales was due to growth in our LIP business and $3.2 million of it was due to royalty income. Currency translation provided an unfavorable variance of $24 million, due primarily to a weakening of the euro versus the U.S. dollar. Turning to Slide 9, volume trends. Changes in unit volume reflect general trends within the industry and timing of customer orders. On the positive side, growth continued in LIP during the quarter from EU LIP implementation and resulting SWM share gain rising 16% over the prior year quarter. We expect strong growth in the second half as customers increase their order levels to meet full year commitments. Reconstituted tobacco sales volume, although down 2% compared to the prior year due to timing of customer orders, were up 5% for the first half. We still expect moderate growth in RTL sales for the total year 2012. Overall paper segment volume declined 10%, including volumes from CTM, our joint venture in China, versus the second quarter of 2011. This was due to reduction in Western world tobacco consumption, timing of customer orders and elimination of unprofitable business in selected areas. Volumes at CTM, our Chinese joint venture, are off to a slower-than-expected start in 2012. However, customers remain committed to their annual forecasted volumes and we should see an improvement during the second half. Year-to-date operating profit, adjusted for $5.3 million of restructuring and impairment charges, increased $24.2 million or 41% from the first half of 2011 due to a $22.6 million benefit of favorable product mix combined with $7.1 million in royalty income. Lower wood pulp prices and other cost of…

Operator

Operator

[Operator Instructions] Your first question comes from the line of Bill Chappell of SunTrust.

William Chappell

Analyst · SunTrust

Just want to get -- as you look out past the next couple of quarters into 2013, kind of an outlook for both RTL and then any update on kind of what you're hearing on LIP into new countries or are we still a quarter or 2 away from that? Frédéric Villoutreix: Okay, so let me focus first on the remainder of the year. So in terms of RTL, we continue to expect very good volume, capacity utilization and as such, strong earnings from the RTL business segment in line with what we have seen year-to-date. And the key for us is to post some incremental growth as we get into 2013 to rebound after a period of '10, '11 being more flattish in terms of volume. And I mean, so far, we have seen that strengthening of the activity and then obviously the major milestone for 2014 will be the start-up of our joint venture in China with expected strong growth from this market in the years '14, '15, 16. For LIP, we are forecasting a very strong second half of 2012, based on customer contractual commitments have been renewed and the momentum that we see as we enter the third quarter. For 2013 and out, in terms of -- the growth will have to come from new territories, new countries adopting LIP regulation. And at this stage, while there are activities at government levels or at the World Health Organization level with a working group dedicated to establishing a global standard for LIP regulation, they have no firm schedule established yet or communicated yet. However, there is some pre-planning work taking place jointly with some of our key customers that lead us to believe that if not in '13, in '14 we should see the addition of new markets that will continue the growth path that we have seen for LIP over the last several years.

William Chappell

Analyst · SunTrust

I understand, and thanks for the color on that. But going back to the RTL front, is there enough activity or if you're looking kind of virgin leaf prices over the next couple of years to actually restart or relook at the Philippines project or is that still probably a ways off? And then on the LIP front, had there been any countries, in addition, that are going this year or even next year that are not as meaningful but just other ones that are moving? Frédéric Villoutreix: So on the RTL side, I think the strength of our volumes this year speaks for the focus that we have on developing new business with an eye on Asia, excluding China. And as such, I think we remain confident that we will restart the RTL Philippines in time. Now with this being said, our priority in terms of capacity addition is the Chinese markets. And it is unlikely that we'll restart our investment in Southeast Asia prior to having established a solid position in China or at least a site to commercially sell products out of our Chinese joint venture. For LIP, I mean, the 2 markets that have adopted LIP regulation this year; one is Switzerland, which is already in effect; the other one is South Africa, which will come the latter part of this year where we intend to build node [ph] in South Africa, so there's clearly going to be a carryover effect into 2013. But both markets are relatively small in size. And again, I think there is an important event later this year in November. The World Health Organization has a seminar with the working commissions reporting on progress in November, in Korea. And that's probably where we could see more clarity as to the schedule for further adoption of LIP regulation.

William Chappell

Analyst · SunTrust

Okay. And then just last one. Jeff, can you maybe just help me on the tax front? Was the higher tax rate this quarter always in your original guidance? And shouldn't we expect, especially as Polish operations going to kick in, tax rate continue to kind of drift lower and lower?

Jeffrey Cook

Analyst · SunTrust

Yes, the higher effective tax rate you saw this quarter was driven by some of the restructuring actions, the impairment on the RTL P equipment being transferred. We didn't take a tax credit on that so that boosted up our effective rate on our overall GAAP earnings per share. And then, we did have a small additional valuation allowance on the Philippines operations. So that's why you saw that numbers remain high. But the outlooks we're giving you are excluding those restructuring and impairment activities and also the tax valuation allowances. I would expect -- for the total year, I would expect to see our effective tax rate probably around 35% or so at the total year, which includes the impact of what we've already seen in the first half. But, again, the things that swing that are some of these unusual impairment entries.

William Chappell

Analyst · SunTrust

So as I move to 2013, getting back down to 30% is more realistic?

Jeffrey Cook

Analyst · SunTrust

Yes, getting down to low 30s is more realistic, yes. And you're right with Poland starting to be more profitable on a lower tax rate, that will help us, yes.

Operator

Operator

Your next question comes from the line of Ann Gurkin of Davenport.

Ann Gurkin

Analyst · Ann Gurkin of Davenport

I wanted to start with -- to follow on some comments you're talking about -- talked about LIP. Is that still on the agenda for the WHO meeting in November? Any changes in that? Frédéric Villoutreix: No, there's no changes on the agenda.

Ann Gurkin

Analyst · Ann Gurkin of Davenport

Okay, great. And then RTL demand looked softer in Q2, is that a timing effect or was there a change in order patterns, I mean, in any of your customer emerged for RTL for the year? Frédéric Villoutreix: I think it's pure timing. As fact, the lumpiness of the RTL business and the fact one quarter to another you will see, in terms of the timing of closing and production orders, some small swings. But really, the demand against our factories remain steady and relatively strong.

Ann Gurkin

Analyst · Ann Gurkin of Davenport

And then -- I guess, this is asked a lot, any price erosion for the LIP business as you look to the back half of '13 -- I'm sorry, '12 and as you go into '13? Frédéric Villoutreix: No, I think as we said before, I mean, we secured fixed pricing agreements with the LIP contracts in Europe with multi-year supply agreements. There is always, outside of Europe, some contract negotiations taking place, but nothing of substance.

Ann Gurkin

Analyst · Ann Gurkin of Davenport

Okay. And then you still generated a good amount of cash flow this year. Jeff, can you comment at all on other potential uses for the cash flow?

Jeffrey Cook

Analyst · Ann Gurkin of Davenport

No, we're looking forward to second half to good generation and now with the stock buyback, very little left in the $50 million. So I think we'll see good generation in the second half.

Ann Gurkin

Analyst · Ann Gurkin of Davenport

Any chance of additional buyback?

Jeffrey Cook

Analyst · Ann Gurkin of Davenport

We haven't even finished the current one yet. So got to get through that and then look at the overall picture again.

Operator

Operator

[Operator Instructions] Your next question comes from the line of Alex Ovshey of Goldman Sachs.

Alex Ovshey

Analyst · Alex Ovshey of Goldman Sachs

A couple of questions. On FX, I was surprised by the magnitude of the impact on the EBIT line. In the past, you've also talked about the impact from changes in the Brazilian currency and you didn't really call that out in the second quarter. So maybe you can just talk to us about any rule of thumbs we should thinking about, about sensitivity to the euro [ph] in Brazil?

Jeffrey Cook

Analyst · Alex Ovshey of Goldman Sachs

In the real, I mean, we have hedging contracts in place going out several years there. So you won't see terrific variations, plus or minus, as the real changes and goes in different directions. So the impact there of any change is muted because a large portion of that is hedged.

Alex Ovshey

Analyst · Alex Ovshey of Goldman Sachs

Got it. So on a go-forward basis, the FX exposure is largely to the euro?

Jeffrey Cook

Analyst · Alex Ovshey of Goldman Sachs

Yes, that's the primary one for us.

Alex Ovshey

Analyst · Alex Ovshey of Goldman Sachs

And is it largely translational? is there any transactional exposure?

Jeffrey Cook

Analyst · Alex Ovshey of Goldman Sachs

No, it's mostly translational of the earnings. I mean, we do some hedging activities on certain transaction activities and balance sheet things. But it's mostly upon the translation of earnings.

Alex Ovshey

Analyst · Alex Ovshey of Goldman Sachs

Got it. Helpful, Jeff. And then any update on litigation in the U.S. post the ITC stuff wrapping up and any change in the competitive landscape in the U.S. now? Saw it in the Q, there was a commentary on Europe around [indiscernible] , I think, challenging some of the patents that you've been granted. If you have any incremental color you'd like to add there, that'd be helpful as well. Frédéric Villoutreix: So Alex, I think on the U.S. front, there's really have been no new developments on the litigation side post the ITC ruling. And on the market's coverage, I think looking at our direct sales, they remain well oriented, strong. Looking at revenue from the license agreements in place, I think we continue to see extremely good coverage of the -- and extraction of value from this segment. In Europe, we have a handful of patent positions that were filed right after our patents, LIG patents got granted over the last few years. We keep seeing new patents granted for us, which strengthen our present portfolio in this strategically important region. And we do expect that those patents get granted to see some position activities. However, there's a position that really not progressed much. That's still in the, let's say, brief paper exchanges mode and so we've nothing of substance to comment at this stage.

Operator

Operator

Your next question is a follow-up from Ann Gurkin of Davenport.

Ann Gurkin

Analyst · Davenport

Just wondered if you can comment on what you've included for volume estimates for the U.S. globally and China now for 2012? Frédéric Villoutreix: So the volume estimates in terms of the growth? Yes, I think, in the U.S., our view it's in line with what is being reported by the major players. So right now, we're talking about, let's say, a 3% attrition rate, which is somewhat slower -- lower level than prior years. The growth in China, at least the first half, was somewhat of a flattish profile, which is quite unusual. I think some of that is the timing of some of the promotional activities and maybe some other production in the second half of 2011. The statistics, as you know, are today, showing or forecasting a growth in the 3%, 3.5% range for China for 2012. And on our side, our joint venture, CTM, as Jeff alluded to in his prepared remarks, we have seen a soft first half due to the timing of orders. However, we are entering the third quarter with strong orders and renewed commitment from customers for the full year demand. And so we continue to grow in China at a faster pace than the overall market because we are positioned there at #1 or #2 supplier on most of the major brands in China, which, through the government program of concentration of cigarette producers and brands is playing to advantage with stronger growth than the average market rate.

Ann Gurkin

Analyst · Davenport

And then in Europe? Frédéric Villoutreix: In Europe, I think, this is kind of a mixed crowd. If I look at the rest of the world, we're talking about the U.S. China and then the rest of the world. I mean, Western Europe certainly, its attrition rate in terms of consumption decline and switch to other tobacco products have been pronounced this year than in prior years. The Eastern European market also is kind of cooling off as well and the growth is primarily coming from key markets in Asia and the Middle East, which obviously [indiscernible] everybody, all cigarette companies and ourselves are concentrating our efforts on.

Ann Gurkin

Analyst · Davenport

So we did have numbers of down 3% or 4%. Is that still a reasonable range for the year? Frédéric Villoutreix: For Europe, yes.

Ann Gurkin

Analyst · Davenport

For Europe. So it's still in line with what you're modeling?

Operator

Operator

At this time, there are no further questions from participants. Gentleman, are there any closing remarks? Frédéric Villoutreix: Well, thank you, Lori, and thank you for everyone attending. Again, we remain confident in the outlook for the balance of the year. The volatility of euro to the dollar lately has only added a little bit of headwind to our earnings. However, when I look at the operating plan, this plan of our strategy remains intact and with growth potential getting into 2013, '14, which, in my mind, is going to continue to carry the earnings of SWM up and we certainly are excited with the stock split and the ability to improve our dividend yield as a result of that action. So we look forward to talking to you all in the coming weeks, and wish you a good day.

Operator

Operator

Thank you for participating in today's SWM's second quarter 2012 earnings conference call. You may now disconnect.